Abstract
Background/Aims: The current study aimed to evaluate the effects of intravenous (IV) lidocaine on sedative requirements, duodenal peristalsis, and procedural outcomes in patients undergoing endoscopic retrograde cholangiopancreatography (ERCP) under deep sedation.
Materials and Methods: In this prospective, randomized, double-blind, placebo controlled study, 120 patients with ASA I–III who were scheduled for elective ERCP were enrolled. Participants were randomized to 2 groups: the lidocaine group (n = 60) received a 1 mg/kg bolus followed by a 2 mg/kg/h infusion, whereas the control group (n = 60) received an equivalent volume of 0.9% saline. Sedation was maintained with propofol and titrated to a Bispectral Index of 60-80. Duodenal peristalsis was assessed using a predefined semiquantitative peristalsis scoring system.
Results: Demographic characteristics were similar between groups. Total propofol consumption was significantly lower in the lidocaine group (P < .001). Recovery and discharge times were significantly shorter in the lidocaine group than in the control group (P < .001 for both). Clinically adequate inhibition of duodenal peristalsis was observed more frequently in the lidocaine group (90.0% vs. 75.0%; P = .031), and the requirement for rescue antispasmodics was lower (P = .018). Complication rates, cannulation time, primary success rate, and endoscopist satisfaction were similar between groups.
Conclusion: IV lidocaine may serve as a supportive anesthetic-sparing adjunct during ERCP, reducing propofol requirements and facilitating shorter recovery times. Although lidocaine was associated with greater inhibition of duodenal peristalsis and reduced use of rescue antispasmodic, major procedural outcomes were comparable between groups; therefore, these findings should be interpreted cautiously.
Cite this article as: Şahap M, Şahap M, Kenarlı K, .demiş B, But A. The effect of intravenous lidocaine on duodenal peristalsis and sedation quality during endoscopic retrograde cholangiopancreatography: A randomized controlled trial. Turk J Gastroenterol. 2026;37(9):995-1005.
Most read articles by the same author(s)
- Mahmut Yüksel, Kerem Kenarlı, Fırathan Sarıaltın, Emine Sena Sözen, Ahmet Akbay, Erdoğan Deniz, Kübra Köken, Çağdaş Erdoğan, Mevlüt Hamamcı, Hasan Tankut Köseoğlu, Six-Month Outcomes of Endoscopic Intragastric Balloon Therapy: A Prospective Single-Center Study , Turkish Journal of Gastroenterology: Vol. 36 No. 11 (2025): Turkish Journal of Gastroenterology
- Volkan Gökbulut, Bülent Ödemiş, Ömer Öztürk, Bülent Yamak, İlyas Tenlik, Selcen Yüsra Abaylı, Handan Öztürk, A Rare Complication of ERCP , Turkish Journal of Gastroenterology: Vol. 33 No. 4 (2022): Turkish Journal of Gastroenterology
- Bülent Ödemiş, Aydın Şeref Köksal, Serkan Torun, Mehmet Yurdakul, Ertuğrul Kayaçetin, Complete biliary obstruction without jaundice due to an anatomic variation , Turkish Journal of Gastroenterology: Vol. 25 No. 1 (2014): Turkish Journal of Gastroenterology

This work is licensed under a Creative Commons Attribution 4.0 International License.